Lucey, M., Ashik, T., Marzook, A., Wang, Y., Goulding, J., Oishi, A., Broichhagen, J., Hodson, D. J., Minnion, J., Elani, Y., Jockers, R., Briddon, S. J., Bloom, S. R., Tomas, A., & Jones, B. (2021). Acylation of the incretin peptide exendin-4 directly impacts glucagon-like peptide-1 receptor signaling and traffickings. Molecular Pharmacology, 100(4), 319-334. https://doi.org/10.1124/molpharm.121.000270